Hunan Childrens Hospital

Changsha, Hunan 410007

6 studies enrolling now · 9 studies all time

What they study most

Atopic Dermatitis, Crohn's Disease, Eczema, Pediatric Migraine, Plaque Psoriasis, Puberty; Precocious, Central, Severe Alopecia Areata, Ulcerative Colitis

Studies at this site

• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema — Recruiting now
• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema — Recruiting now
• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis — Recruiting now
• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis — Recruiting now
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Recruiting now
• Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty — Completed
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata — Running, not enrolling